Clinical and pathological features of hereditary prostate cancer

J Urol. 1996 Jun;155(6):1841-3.

Abstract

Purpose: We determined whether the clinical and pathological features of hereditary prostate cancer differ from those of sporadic prostate cancer.

Materials and methods: We compared the clinical and pathological features of radical prostatectomy specimens from 50 men with and 50 without a family history of prostate cancer who were matched for age and date of surgery.

Results: Median serum prostate specific antigen concentration was not significantly different in the 2 groups. Mean Gleason score plus or minus standard deviation in the 50 men with sporadic prostate cancer was 6.2 +/- 1 compared to 5.6 +/- 0.9 in those with hereditary disease (p = 0.008). Of the 50 hereditary and 50 sporadic prostate cancers 35 (70%) and 33 (66%), respectively, were pathologically organ confined (p = 0.69). Median percentage of carcinoma within the gland (determined morphometrically) in men with hereditary disease was 11.4 +/- 8.3 compared to 10.9 +/- 8.9 for those with sporadic cancer (p = 0.63).

Conclusions: In our study population hereditary prostate cancers have significantly lower Gleason scores compared to sporadic carcinomas. Otherwise, there appear to be no substantial clinical or pathological differences.

Publication types

  • Comparative Study

MeSH terms

  • Age of Onset
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prostate / pathology*
  • Prostate-Specific Antigen / blood*
  • Prostatectomy
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / surgery
  • Retrospective Studies
  • Risk Factors

Substances

  • Prostate-Specific Antigen